The Prognostic Utilities of DNA Mismatch Repair Status and KRAS and BRAF Mutation in Korean Colorectal Cancer Patients: The KASID Multicenter Study
Sign Up to like & getrecommendations! Published in 2022 at "Oncology"
DOI: 10.1159/000527285
Abstract: Introduction: KRAS, BRAF, and DNA mismatch repair (MMR) mutations aid clinical decision-making for colorectal cancer (CRC) patients. To ensure accurate predictions, the prognostic utilities of these biomarkers and their combinations must be individualized for patients… read more here.
Keywords: kras braf; mismatch repair; dna mismatch; prognostic utilities ... See more keywords